Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sherman

Showing results (361-370 of 390) with videos related to

Pageof 39
Sort By:
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Blood|May 12, 2023
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label StudyMatthew P Cheng, Isabel H Gonzalez-Bocco, Esther Arbonna-Haddad, et al.
Vaccine|October 17, 2024
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adultsVarun K Phadke, Daniel J Gromer, Paulina A Rebolledo, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaPranay R Randad, Nora Pisanic, Kate Kruczynski, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 19, 2023
Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry GroupKaloyan S Tanev, Joan A Camprodon, David N Caplan, et al.
Pageof 39

Showing results (361-370 of 390) with videos related to

Sort By:
Pageof 39
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Blood|May 12, 2023
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label StudyMatthew P Cheng, Isabel H Gonzalez-Bocco, Esther Arbonna-Haddad, et al.
Vaccine|October 17, 2024
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adultsVarun K Phadke, Daniel J Gromer, Paulina A Rebolledo, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaPranay R Randad, Nora Pisanic, Kate Kruczynski, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 19, 2023
Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry GroupKaloyan S Tanev, Joan A Camprodon, David N Caplan, et al.
Pageof 39